Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

127.58

-6.77 (-5.04%)

At close: May 11, 2026, 4:00 PM EDT

131.25

+3.67 (2.88%)

After-hours: May 11, 2026, 7:57 PM EDT

Inhibrx Biosciences Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Inhibrx Biosciences stock has a target of 150, which predicts a 17.57% increase from the current stock price of 127.58.

Price Target: $150 (+17.57%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$150	$150	$150	$150
Change	+17.57%	+17.57%	+17.57%	+17.57%

* Price targets were last updated on Apr 8, 2026.

Analyst Ratings

The average analyst rating for Inhibrx Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	0	0	0	0	1	1
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dara Azar Stifel	Stifel	Strong Buy Initiates $150	Strong Buy	Initiates	$150	+17.57%	Apr 8, 2026
Reni J. Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 22, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 15, 2025
Reni Benjamin Citizens Capital Markets	Citizens Capital Markets	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 18, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jan 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.30M

Revenue Next Year

55.13M

EPS This Year

-8.47

from -9.04

EPS Next Year

-6.20

from -8.47

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.23M	1.32M	1.80M	200.00K	1.30M	-	55.13M
Revenue Growth	-43.89%	-81.81%	36.88%	-88.89%	550.00%	-	-
EPS	-2.15	-2.88	-20.48	112.62	-9.04	-8.47	-6.20
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	56.8M
Avg	n/a	55.1M
Low	n/a	53.0M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-5.74	-2.93
Avg	-8.47	-6.20
Low	-10.93	-9.19

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.